<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_UC_Davis_project"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:UC_Davis/project">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:UC_Davis/project&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:UC_Davis/project&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:UC_Davis/project&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:UC_Davis/project" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:UC Davis/project</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><P><TITLE>lol</TITLE></P><DIV style="text-align: center;"><B style="color: rgb(0, 0, 0);"> </B><B style="color: rgb(255, 255, 153);"><SPAN style="font-size: 13.5pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><BIG><BIG><BIG><BIG> </BIG></BIG></BIG></BIG></SPAN></B><DIV style="text-align: left;"><B style="color: rgb(0, 0, 0);"><BIG><BIG>Project:</BIG></BIG></B><DIV style="text-align: center;"><B style="color: rgb(0, 0, 0);"><A href="#celiac_disease">Celiac
Disease</A>         <A href="#current_treatment">Current
treatment</A>          <A href="#our_approach">
Our Approach</A></B></DIV><SMALL><U><SPAN style="font-size: 20pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><SPAN style="font-weight: bold;">Celiac Disease:</SPAN></SPAN></U></SMALL><I><SPAN style="font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">What
is Celiac Disease?</SPAN></I><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">          Celiac
Disease is a form of autoimmune disorder, which occurs inside the small
intestine. When the body cannot digest gliadin (component of gluten)
properly,
this leads to an immune response (14). Furthermore, different people
have
different reactions to these immune responds such as pain and vomiting
(14). It
has been estimated that about one out of 133 Americans are currently
suffering
from this disease (11); including one of our teammate's friends, and
that was
what sparked our interest in designing this project.</SPAN><SPAN style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><SPAN style="">                                          </SPAN></SPAN><SPAN style="font-style: italic;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">
What happens in the normal small
intestine?</SPAN></SPAN><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">          In
the normal small intestine, the Brush border membrane lets small
peptides and
molecules like water through and into the bloodstream. The brush border
membrane also lets larger molecules into the blood stream, similar to
Gliadin;
however, these larger molecules are converted through a transcellular
route, which
does not prompt an immune system response.</SPAN><I><SPAN style="font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">
What
happens in celiac disease small intestine?</SPAN></I><I><SPAN style="font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><SPAN style="">            </SPAN></SPAN></I><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">          The
Brush border membrane in the small intestine of people suffering from
Celiac Disease
allows large molecules such as gliadin to go straight into the blood
stream
without directing them through the transcellular route. Once gliadin
passes
through, Antigen Presenting Cells (APCs) recognize gliadin as a foreign
object
and will attack. This immune response causes pain and other adverse
side-effects.</SPAN><P class="MsoNormal" style="text-indent: 0.5in;"><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">The
immune response not only causes abdominal bloating, pain, weight loss
and
vomiting, most of the time it may also damage intestinal villi, which
are
important for absorbing nutrition. The destruction of villi eventually
leads to
a lack of absorption of different nutrients, which can lead to other
illnesses
(14). Some people affected with this disorder can also suffer from </SPAN><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">autoimmune
thyroid disease, autoimmune liver disease, rheumatoid arthritis </SPAN><I><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">(diseases
in which body immune system attacks healthy cells/tissues)</SPAN></I><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">
(14).</SPAN></P><P class="MsoListParagraph" style=""><U><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><BIG><BIG><SPAN style="font-weight: bold;">Current
treatments:</SPAN></BIG></BIG></SPAN></U></P><P class="MsoNormal" style="line-height: normal;"><B><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">          </SPAN></B><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Currently,
no cure has been found
for this illness. The only way to avoid some of celiac disease’s
symptoms is by
adopting a gluten free diet (14, 12, and 11). However, you are more
likely to
find gluten in your everyday diet. Therefore, avoiding gluten is not
easy or
pleasant from a gastronomical standpoint.</SPAN><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">      
&quot;Oral supplementation with prolyl oligopeptidases has therefore been
proposed
as a potential therapeutic approach.&quot;(8). However, enzymes studied
earlier
were not able to degrade gluten (inside stomach before it reaches small
intestine because they were &quot;irreversibly inactivated by pepsin and
acidic
pH, both present in the stomach.&quot;(8)</SPAN><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">        
Nevertheless, over the past years, researchers have discovered an
enzyme from <I>Aspergillus
niger</I>, a newly identified prolyl endoprotease, that was observed to
&quot;work optimally at 4-5pH and remains stable at 2pH&quot;(8) and maybe this
enzyme will lead us to an alternative treatment for this disorder (8).
Studies
have shown that prolyl-endoprotease from <I>Aspergillus niger</I> is
able to
&quot;degrade gluten in vitro and under conditions similar to the ones
present
in the gastrointestinal tract.&quot; (8) ; but due to licensing restrictions
we
have opted not to work with this protein.</SPAN><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">          
Recently (year 2007), a study has suggested an alternative approach by
combining a glutamine-specific endoprotease (EP-B2 from barley) and a
prolyl
endopeptidase (SC PEP from Sphingomonas capsulata); with gastric
activity and
complementary substrate specificity there is a possibility of
increasing the
safe threshold of ingested gluten (12). One of the advantages of this
“combination product is that both enzymes are active and stable in
stomach and
can therefore be administered as lyophilized powders or simple capsules
or
tablets” (12).</SPAN></P><P class="MsoNormal" style="line-height: normal;"><I><SPAN style="font-size: 12pt; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Note:
Moreover, this study was first
“evaluated via in vitro digestion of whole-wheat beard and then
confirmed by in
vivo studies in rats (12), unlike other earlier studies which were
performed on
synthetic gluten oligopeptides, recombinant gliadin proteins, or
uncooked
gluten” (12).</SPAN></I></P><B><U><SPAN style="font-size: 20pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">Our
approach:</SPAN></U></B><P class="MsoNormal"><SPAN style="font-size: 16pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><SPAN style="">         </SPAN></SPAN><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;">We
are going to break down gluten inside the stomach (before it arrives to
the
small intestine), because gliadin does not prompt an immune system
response until
it is absorbed in the small intestine.<SPAN style=""> </SPAN>Another worry is a spread of our synthetic bug, so we engineered
a
‘safety-switch’ via induction of cell death through a pH sensor system.<SPAN style=""> </SPAN>Due to the change of pH from the stomach to
the small intestine, our pH system is induced; cell death, thus
limiting our
bug to the stomach.</SPAN></P><P class="MsoNormal"><SPAN style="font-size: 12pt; line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><SPAN style="">           </SPAN>The
advantages of our model are, that unlike other suggested treatments
which
require consuming capsules or tablets rapidly, by using <I><SPAN style="color: black;">Escherichia coli</SPAN></I><SPAN style="color: black;"> as
our model chassis for this project: we can lower the number of times
which this
‘cure’ needs to be consumed thus making it less troublesome, costly,
and more
convenient.</SPAN></SPAN></P><P class="MsoNormal"><SPAN style="font-weight: bold;">Our project is
split into two parts:</SPAN>
1.Induced Secretion</P><UL><LI><A href="https://2009.igem.org/Team:UC_Davis/Gene_sequence_for_secretion_system">Gene
sequence for secretion system</A></LI><LI><A href="https://2009.igem.org/Team:UC_Davis/Adding_secretion">Adding
secretion</A></LI><LI><A href="https://2009.igem.org/Team:UC_Davis/assay_for_measuring_protein_localization_and_activity">Assay
for measuring protein localization and activity</A></LI></UL>
2.Sensing pH  and inducing cell death<UL><LI><A href="https://2009.igem.org/Team:UC_Davis/Project1/Finding_ph_sensor">Finding
an appropriate biological pH sensor</A></LI><LI><A href="https://2009.igem.org/Team:UC_Davis/wiring_pH_sensor">Wiring
the pH sensor into our system</A></LI><LI><A href="https://2009.igem.org/Team:UC_Davis/assay_for_pH_sensor">Assay
for measuring the behavior of the pH sensor</A></LI></UL></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:UC_Davis/project">http://2009.igem.org/Team:UC_Davis/project</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:UC_Davis/project" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:UC_Davis/project" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:UC_Davis/project&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:UC_Davis/project&amp;oldid=76872" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>